| Document Date: 2014-11-07 05:21:11
Open Document File Size: 303,71 KBShare Result on Facebook
City Copenhagen / / Company BP / Novartis / GSK / Lilly / Sanofi / CLL / Zymeworks / Janssen / / Country United States / Sweden / Denmark / / Currency EUR / / / Event FDA Phase / Business Partnership / / IndustryTerm online dialogue / online network / online chat communication / financial media / investor meetings / online marketing / / Organization FDA / European Union / / Person JAN VAN DE WINKEL Q / Jan Van de Winkel Ofatumumab / JAN VAN DE WINKEL / David Eatwell / / / Position CEO / private investor / CFO / / Product Daratumumab / / RadioStation 2014 WITH / / Technology ADC / antibodies / / URL www.tcpdf.org / www.proinvestor.com/ir/en / /
SocialTag |
Q&A GENMAB 6TH OF NOVEMBER 2014 WITH JAN VAN DE WINKEL Q&A GENMAB 6TH OF NOVEMBER 2014